Tango Therapeutics, Inc. - Common Stock (NQ:TNGX)
19.89
-0.15
(-0.75%)
Streaming Delayed Price
Updated: 10:46 AM EDT, May 27, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 464,510 |
| Open | 20.04 |
| Bid (Size) | 19.84 (200) |
| Ask (Size) | 19.90 (100) |
| Prev. Close | 20.04 |
| Today's Range | 19.77 - 20.41 |
| 52wk Range | 1.905 - 28.41 |
| Shares Outstanding | 88,406,523 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
A Peek at Tango Therapeutics's Future Earnings ↗
November 03, 2025
Wondering what's happening in today's pre-market session? ↗
October 23, 2025
Frequently Asked Questions
Is Tango Therapeutics, Inc. - Common Stock publicly traded?
Yes, Tango Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Tango Therapeutics, Inc. - Common Stock trade on?
Tango Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tango Therapeutics, Inc. - Common Stock?
The ticker symbol for Tango Therapeutics, Inc. - Common Stock is TNGX on the Nasdaq Stock Market
What is the current price of Tango Therapeutics, Inc. - Common Stock?
The current price of Tango Therapeutics, Inc. - Common Stock is 19.89
When was Tango Therapeutics, Inc. - Common Stock last traded?
The last trade of Tango Therapeutics, Inc. - Common Stock was at 05/27/26 10:46 AM ET
What is the market capitalization of Tango Therapeutics, Inc. - Common Stock?
The market capitalization of Tango Therapeutics, Inc. - Common Stock is 1.76B
How many shares of Tango Therapeutics, Inc. - Common Stock are outstanding?
Tango Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.